uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Production of chemokinetic inhibitory factor (CIF) by normal blood and spleen B lymphocytes
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences.
Show others and affiliations
1986 (English)In: Leukemia research: a Forum for Studies on Leukemia and Normal Hemopoiesis, ISSN 0145-2126, E-ISSN 1873-5835, Vol. 10, no 2, 179-186 p.Article in journal (Other academic) Published
Abstract [en]

We have recently reported the partial purification and characterization of of a new lymphokine, the heat-labile chemokinetic inhibitory factor (CIF) which inhibits neutrophil movement. We have also shown that this lymphokine is produced and secreted by cultured B-chronic lymphocytic leukaemia (CLL) cells in vitro. The present study shows that highly purified resting normal B lymphocytes from blood and spleen have the capacity to produce CIF spontaneously. After activation with anti-IgM or EBV-infection the lymphocytes produced a number of other factors, heat-stable chemokinetic inhibitory factors and heat-labile chemokinetic enhancing factors. Supernatants from a collection of human B-cell lines representing different stages of B-cell differentiation were also investigated. None of these cell lines produced CIF. The present results show that the production of CIF is not restricted to the malignant B-CLL cell but is also produced by a subset of normal blood and spleen B cells.

Place, publisher, year, edition, pages
1986. Vol. 10, no 2, 179-186 p.
Keyword [en]
B-Lymphocytes/cytology/*immunology, Cell Line, Cell Separation, Cells; Cultured, Chemotactic Factors/antagonists & inhibitors, Humans, Leukemia; Lymphocytic, Lymphokines/*biosynthesis/blood, Lymphoma, Multiple Myeloma, Neutrophils/cytology, Research Support; Non-U.S. Gov't, Spleen/*immunology
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:uu:diva-73258PubMedID: 3485223OAI: oai:DiVA.org:uu-73258DiVA: diva2:101169
Available from: 2005-06-01 Created: 2005-06-01 Last updated: 2017-12-14Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=3485223&dopt=Citation

Authority records BETA

Siegbahn, Agneta

Search in DiVA

By author/editor
Siegbahn, Agneta
By organisation
Department of Medical Sciences
In the same journal
Leukemia research: a Forum for Studies on Leukemia and Normal Hemopoiesis
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 488 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf